Intel 570% Past Year: Buy the Comeback or Take Profits?
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesIntel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
Smart investing isn’t about chasing the hottest story. It’s about owning durable businesses that quietly compound val...
As SpaceX moves deeper into the public market, investors face a volatile ride. This article lays out credible scenari...
Investors are eyeing Vera Bradley's 2026 path as it rhythms through product launches, wholesale relationships, and di...
Investors pushed Microsoft higher as AI software leadership and new deals fueled optimism. This deep dive explains th...
Investing in Coca-Cola offers more than a familiar brand. This guide breaks down the five-year outlook, key drivers, ...
A blockbuster year for Delek US Holdings brought attention to a notable insider move. The event described as delek in...
A growth stock has fallen sharply, trading hands at levels that look oversold. This article breaks down whether the d...
Two heavyweights vie for leadership in AI cooling and data-center resilience. This guide breaks down which stock—NVEN...
Astera Labs stands at an inflection point: rapid AI demand could lift the stock, but margin pressures and a premium v...
Morgan Stanley's 2026 outlook hinges on wealth management growth, trading environment, and disciplined capital manage...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...